UBC PiMS Research Group
Pharmacoepidemiology in Multiple Sclerosis Research Group

What’s new for ‘microbiota multiple sclerosis’ in PubMed

Ann Neurol. 2017 Feb 21. doi: 10.1002/ana.24901. [Epub ahead of print]

The gut microbiome in human neurological disease: A review.

Abstract

Almost half the cells and 1% of the unique genes found in our bodies are human, the rest are from microbes; predominantly bacteria, archaea, fungi, and viruses. These microorganisms collectively form the human microbiota, with most colonizing the gut. Recent technological advances, open access data-libraries, and application of high throughput sequencing have allowed these microbes to be identified and their contribution to neurological health examined. Emerging evidence links perturbations in the gut microbiota to neurological disease, including disease risk, activity, and progression. This review provides an overview of the recent advances in microbiome research in relation to neuro(auto)immune and neurodegenerative conditions affecting humans such as multiple sclerosis, neuromyelitis optica spectrum disorders, Parkinson’s, Alzheimer’s, Huntington’s, and amyotrophic lateral sclerosis. Study design and terminology used in this rapidly evolving, highly multi-disciplinary field are summarized to empower and engage the neurology community in this ‘newly discovered organ.’ This article is protected by copyright. All rights reserved.

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia